pic from google

BioNTech decides to develop the treatment of malaria by mRNA technology-based vaccine. BioNTech is the company that developed the COVID-19 vaccine with Pfizer. It will clinically test the mRNA technology-based malaria vaccine by the end of 2022. This company is exploring vaccine production in Africa to enhance the manufacturing capacity and to ease global access to the vaccine.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Swedish Security Services hold a probe into drones incident

Stockholm: Sweden’s Security Service said in a statement that it had taken…

Pak Navy successfully test-fires surface-to-air missiles

Pakistan Navy on Thursday exhibited an excellent display of firing surface-to-air missiles…

Vakeel Online, a promising future for lawyers

Lahore: Last Saturday, Vakeel Online, a promising legal technology start-up, and online…

K-P govt to solarize 9,000 mosques

Khyber-Pakhtunkhwa (K-P) government has solarized 6,500 mosques across the province while conversion…